These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18651997)

  • 21. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.
    Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP
    Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of metformin for weight management in patients without type 2 diabetes.
    Desilets AR; Dhakal-Karki S; Dunican KC
    Ann Pharmacother; 2008 Jun; 42(6):817-26. PubMed ID: 18477733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin in an Adolescent with Significant Weight Gain.
    Salau M; Adam B; Coffey BJ
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):589-92. PubMed ID: 26375769
    [No Abstract]   [Full Text] [Related]  

  • 24. Metformin: an effective attenuator of risperidone-induced insulin resistance hyperglycemia and dyslipidemia in rats.
    Adeneye AA; Agbaje EO; Olagunju JA
    Indian J Exp Biol; 2011 May; 49(5):332-8. PubMed ID: 21615056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs.
    Hasnain M; Fredrickson SK; Vieweg WV
    J Psychopharmacol; 2011 Jun; 25(6):715-21. PubMed ID: 21169390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gaining: pediatric patients and use of atypical antipsychotics.
    Towbin KE
    Am J Psychiatry; 2006 Dec; 163(12):2034-6. PubMed ID: 17151148
    [No Abstract]   [Full Text] [Related]  

  • 27. Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment: Meta-Analysis of Randomized Placebo-Controlled Trials.
    Zheng W; Li XB; Tang YL; Xiang YQ; Wang CY; de Leon J
    J Clin Psychopharmacol; 2015 Oct; 35(5):499-509. PubMed ID: 26280837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Description of a healthy lifestyle intervention for people with serious mental illness taking second-generation antipsychotics.
    Park T; Usher K; Foster K
    Int J Ment Health Nurs; 2011 Dec; 20(6):428-37. PubMed ID: 21564457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between weight and medications in psychological illnesses of children.
    Apter A; Steingart L
    World Rev Nutr Diet; 2013; 106():174-80. PubMed ID: 23428698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of metformin to control clozapine-associated weight gain in an adolescent with schizoaffective disorder.
    Weaver LA; De León DD; Borgmann-Winter K; Coffey BJ
    J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):153-7. PubMed ID: 20415612
    [No Abstract]   [Full Text] [Related]  

  • 31. Metformin induced anorexia and weight loss.
    Wong LL; Wong TC
    Hawaii Med J; 2003 May; 62(5):104-5. PubMed ID: 12806790
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.
    Kebapcilar L; Taner CE; Kebapcilar AG; Alacacioglu A; Sari I
    Arch Gynecol Obstet; 2010 Jan; 281(1):35-42. PubMed ID: 19330342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involuntary Weight Loss Secondary to Metformin Use in Elderly Adults.
    Pérez-Hernández O; González-Pérez JM; Martínez-Riera A; Durán-Castellón Mdel C; Monereo-Muñoz MB; Martín-González C; Santolaria-Fernández F
    J Am Geriatr Soc; 2016 Apr; 64(4):899-900. PubMed ID: 27100596
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight loss and anorexia with quetiapine.
    Khawaja IS; Azeem MW; Ebrahim A
    Psychiatr Serv; 2005 Apr; 56(4):490. PubMed ID: 15812105
    [No Abstract]   [Full Text] [Related]  

  • 36. Weight beneficial treatments for type 2 diabetes.
    Meneghini LF; Orozco-Beltran D; Khunti K; Caputo S; Damçi T; Liebl A; Ross SA
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3337-53. PubMed ID: 21900381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics.
    Weber M; Wyne K
    Schizophr Res; 2006 Mar; 83(1):95-101. PubMed ID: 16507343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes.
    Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
    Diabet Med; 2012 Dec; 29(12):1515-23. PubMed ID: 22540883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study.
    Wang M; Tong JH; Zhu G; Liang GM; Yan HF; Wang XZ
    Schizophr Res; 2012 Jun; 138(1):54-7. PubMed ID: 22398127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The comparative efficacy of lifestyle intervention and metformin by educational attainment in the Diabetes Prevention Program.
    O'Brien MJ; Whitaker RC; Yu D; Ackermann RT
    Prev Med; 2015 Aug; 77():125-30. PubMed ID: 26024851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.